TELO · Telomir Pharmaceuticals, Inc. · Executive Compensation
$1.01
-0.03 (-2.88%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report.”View the 10-Q filed Aug 13, 2026
Market Cap
$71.53M
Shares
68.77M
Volume · Oct 20
77.96K
Avg daily vol (3M)
92.57K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Erez Aminov | (Chairman and CEO) | $4,880,350 |
| Michelle Yanez | (Former CFO, Treasurer, and Secretary) | $106,869 |
| Christopher Chapman | (Former Chairman and CEO) | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Erez Aminov | (Chairman and CEO) | $7,629,975 |
| Michelle Yanez | (Former CFO, Treasurer, and Secretary) | $865,409 |
| Nathen Fuentes | (Former CFO, Treasurer, and Secretary) | $226,884 |
| Christopher Chapman | (Former Chairman and CEO) | $156,838 |
| Alan Weichselbaum | (Former CFO, Treasurer and Secretary) | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andriy Mushak | Fractional Chief Financial Officer | Appointed | 2026-06-08 |
| Edward MacPherson | director | Appointed | 2026-03-27 |
| Matthew Del Giudice, M.D. | director | Appointed | 2026-03-27 |
| Matthew Whalen | director | Appointed | 2026-03-27 |
| Erez Aminov | director | Appointed | 2026-03-27 |
| Craig Eagle | member of the Board of Directors | Resigned | 2025-11-20 |
| Alan Weichselbaum | Chief Financial Officer | Appointed | 2025-05-21 |
| Michelle Yanez | Chief Financial Officer, Treasurer and Secretary | Resigned | 2025-05-21 |
| Matthew Pratt Whalen | Chairman of the Audit Committee | Appointed | 2024-11-21 |
| Dr. Matthew Del Giudice | member of the Audit Committee | Appointed | 2024-11-21 |
| Michael Jerman | Chair of the Audit Committee of the Company | Resigned | 2024-11-21 |
| Michael Jerman | member of the Board of Directors of the Company | Resigned | 2024-11-21 |
| Michelle Yanez | Chief Financial Officer | Appointed | 2024-06-24 |
| Nathen Fuentes | Chief Financial Officer | Resigned | 2024-06-24 |
| Christos Nicholoudis, Esq. | member of the Board of Directors | Resigned | 2024-04-12 |
| Christos Nicholoudis, Esq. | General Counsel | Resigned | 2024-04-12 |
Leadership
- Christopher Chapman CEO
- Erez Aminov CEO, Board Member
- Alan Weichselbaum CFO
- Andriy Mushak CFO
- Michelle Yanez CFO
- Edward MacPherson Board Member
- Matthew Del Giudice Board Member
- Matthew Del Giudice, M.D. Board Member
- Matthew Pratt Whalen Board Member
- Matthew Whalen Board Member